⌘K
Loading ticker…
As of 2026-08-24, Xenon Pharmaceuticals Inc (XENE) has a 3-month relative strength percentile of 70 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 60. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.5%, relative volume 0.98×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
XENE is held by 28 ETFs as of May 2026. Top owner: VTWO at 0.14% weight, $24M notional. Top 3 carry $33M.
Held by 53 ETFs · $273M across latest filings · largest weight 4.79% (IBRN).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| $1M |
| +0.07 pp |
| ONEQ | 0.01% | $1M | — |
| ESGV | 0.01% | $1M | — |
| FMED | 1.92% | $786K | +0.81 pp |
| VFMO | 0.04% | $784K | new |
Showing 10 of 28 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XENE Jan avg: -2.30% median: -1.34% win: 25% σ: 4.44% n: 4 2022-04-12 → 2026-07-31 | XENE Feb avg: 0.83% median: 2.66% win: 75% σ: 5.81% n: 4 2022-04-12 → 2026-07-31 | XENE Mar avg: 1.76% median: -9.05% win: 25% σ: 21.84% n: 4 2022-04-12 → 2026-07-31 | XENE Apr avg: 1.21% median: -3.63% win: 40% σ: 11.29% n: 5 2022-04-12 → 2026-07-31 | XENE May avg: -8.86% median: -6.35% win: 0% σ: 8.91% n: 5 2022-04-12 → 2026-07-31 | XENE Jun avg: 7.31% median: 8.49% win: 80% σ: 6.22% n: 5 2022-04-12 → 2026-07-31 | XENE Jul avg: 3.38% median: 3.83% win: 60% σ: 6.59% n: 5 2022-04-12 → 2026-07-31 | XENE Aug avg: 10.73% median: 11.33% win: 75% σ: 14.37% n: 4 2022-04-12 → 2026-07-31 (current) | XENE Sep avg: -4.51% median: -4.69% win: 25% σ: 6.83% n: 4 2022-04-12 → 2026-07-31 | XENE Oct avg: 0.22% median: 2.85% win: 75% σ: 6.48% n: 4 2022-04-12 → 2026-07-31 | XENE Nov avg: 7.31% median: 5.19% win: 100% σ: 7.52% n: 4 2022-04-12 → 2026-07-31 | XENE Dec avg: 6.25% median: 3.57% win: 75% σ: 14.47% n: 4 2022-04-12 → 2026-07-31 |